The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis
Open accessAbstract
with ABT-263 (navitoclax) effectively treats established fibrosis in a mouse model of scleroderma dermal fibrosis by inducing myofibroblast apoptosis. Using a BH3 profiling assay to assess mitochondrial priming in dermal fibroblasts derived from patients with scleroderma, we demonstrate that the extent of apoptosis induced by BH3 mimetic drugs correlates with the extent of their mitochondrial priming, indicating that BH3 profiling could predict apoptotic responses of fibroblasts to BH3 mimetic drugs in patients with scleroderma. Together, our findings elucidate the potential efficacy of targeting myofibroblast antiapoptotic proteins with BH3 mimetic drugs in scleroderma and other fibrotic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This increased stiffness is an important survival signal for myofibroblasts; via mechanosensing such stiffness results in intracellular activation of Rho and Rho-associated kinase (ROCK) whose activity increases BCL2-XL expression (36).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [36]
In the citing paper
“Recently, it has been shown that pharmacological inhibition of BCL2-XL can mimic this process and induce targeted BIM-mediated apoptosis in myofibroblasts and even revert established (murine) fibrosis (36).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [36]
In the citing paper
“Importantly, this increased, stiffness-induced, BCL2-XL expression is needed to counteract the function of the pro-apoptotic protein BIM (36). BIM is an activator of BAX and accumulates in myofibroblasts exposed to a stiff matrix. This accumulation primes the cells to undergo apoptosis (36), and only the continued presence of BCL2-XL prevents this.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gurtner, G. C., Werner, S., Barrandon, Y., & Longaker, M. T. (2008) · Nature · doi:10.1038/nature07039 · Cited by 6,542
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
The BCL-2 protein family: opposing activities that mediate cell death
Youle, R. J., & Strasser, A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2308 · Cited by 4,806
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,407
Self-citationControl of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3722 · Cited by 3,219
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3048 · Cited by 3,058
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5836 · Cited by 1,992
Fibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428
Cited by
Sorted by citations
Mitochondria as multifaceted regulators of cell death
Bock, F. J., & Tait, S. W. G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0173-8 · Cited by 2,531
Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine
Dey, A., Varelas, X., & Guan, K.-L. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0070-z · Cited by 860
Self-citationEvasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Hinz, B., & Lagares, D. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0324-5 · Cited by 642
Self-citationCancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
Liu, T., Zhou, L., Li, D., Andl, T., & Zhang, Y. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00060 · Cited by 446
“Navitoclax (ABT-263) is a small molecule that was shown to have the ability to induce apoptosis in myofibroblasts (Lagares et al., 2017).”
BackgroundGibb, A., Lazaropoulos, M. P., & Elrod, J. W. (2020) · Circulation Research · doi:10.1161/circresaha.120.316958 · Cited by 467
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Vitale, I., Pietrocola, F., Guilbaud, E., Aaronson, S. A., Abrams, J., Adam, D., Agostini, M., Agostinis, P., Alnemri, E. S., Altucci, L., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01153-w · Cited by 352
Cell Death in the Lung: The Apoptosis–Necroptosis Axis
Sauler, M., Bazan, I. S., & Lee, P. J. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114320 · Cited by 327
Revisiting fibrosis in inflammatory bowel disease: the gut thickens
D’Alessio, S., Ungaro, F., Noviello, D., Lovisa, S., Peyrin‐Biroulet, L., & Danese, S. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00543-0 · Cited by 262
Myofibroblasts: Function, Formation, and Scope of Molecular Therapies for Skin Fibrosis
Tai, Y., Woods, E. L., Dally, J., Kong, D., Steadman, R., Moseley, R., & Midgley, A. C. (2021) · Biomolecules · doi:10.3390/biom11081095 · Cited by 257
The Role of Myofibroblasts in Physiological and Pathological Tissue Repair
Schuster, R., Younesi, F., Ezzo, M., & Hinz, B. (2023) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041231 · Cited by 232
Mitochondrial dysfunction in fibrotic diseases
Li, X., Zhang, W. Y., Cao, Q., Wang, Z., Zhao, M., Xu, L., & Zhuang, Q. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00316-9 · Cited by 229
Myofibroblast in Kidney Fibrosis: Origin, Activation, and Regulation
Yuan, Q., Tan, R. J., & Liu, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8871-2_12 · Cited by 230
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis
Haak, A. J., Kostallari, E., Sicard, D., Ligresti, G., Choi, K. M., Caporarello, N., Jones, D. L., Tan, Q., Meridew, J. A., Espinosa, A. M. D., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau6296 · Cited by 227
Self-citationFletcher-Sananikone, E., Kanji, S., Tomimatsu, N., Di Cristofaro, L. F. M., Kollipara, R. K., Saha, D., Floyd, J. R., Sung, P., Hromas, R., Burns, T. C., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0752 · Cited by 212
Singh, P., & Lim, B. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01199-y · Cited by 222
Therapeutic approaches to control tissue repair and fibrosis: Extracellular matrix as a game changer
Walraven, M., & Hinz, B. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.02.020 · Cited by 199
Chung, L., Maestas, D. R., Lebid, A., Mageau, A., Rosson, G. D., Wu, X., Wolf, M. T., Tam, A. J., Vanderzee, I., Wang, X., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax3799 · Cited by 175
Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent
Anuar, N. N. M., Hisam, N. S. N., Liew, S. L., & Ugusman, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.564108 · Cited by 177
Lipid Mediators Regulate Pulmonary Fibrosis: Potential Mechanisms and Signaling Pathways
Suryadevara, V., Ramchandran, R., Kamp, D. W., & Natarajan, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124257 · Cited by 171
Pathophysiology of systemic sclerosis (scleroderma)
Rosendahl, A.-H., Schönborn, K., & Krieg, T. M. (2022) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12505 · Cited by 173
Unraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
Cancer-Associated Fibroblasts: Understanding Their Heterogeneity
Louault, K., Li, R., & DeClerck, Y. A. (2020) · Cancers · doi:10.3390/cancers12113108 · Cited by 162
Mechano-therapeutics: Targeting Mechanical Signaling in Fibrosis and Tumor Stroma
Tschumperlin, D. J., & Lagares, D. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107575 · Cited by 146
Self-citationSecretion of leukotrienes by senescent lung fibroblasts promotes pulmonary fibrosis
Wiley, C. D., Brumwell, A. N., Davis, S. S., Jackson, J., Valdovinos, A., Calhoun, C., Alimirah, F., Castellanos, C. A., Ruan, R., Wei, Y., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130056 · Cited by 136
Emerging targets of disease-modifying therapy for systemic sclerosis
Volkmann, E. R., & Varga, J. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0184-z · Cited by 132
Mechanisms for the Resolution of Organ Fibrosis
Horowitz, J. C., & Thannickal, V. J. (2018) · Physiology · doi:10.1152/physiol.00033.2018 · Cited by 135
Senotherapeutics: targeting senescence in idiopathic pulmonary fibrosis
Merkt, W., Bueno, M., Mora, A. L., & Lagares, D. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.12.008 · Cited by 119
Self-citationMatrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play
Chuliá‐Peris, L., Carreres-Rey, C., Gabasa, M., Alcaraz, J., Carretero, J., & Pereda, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136894 · Cited by 126
Tanner, L., Single, A., Bhongir, R. K. V., Heusel, M., Mohanty, T., Karlsson, C. A. Q., Pan, L., Clausson, C.-M., Bergwik, J., Wang, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36314-5 · Cited by 111
Wang, Z., Chen, L., Huang, Y., Luo, M., Wang, H., Jiang, Z., Zheng, J., Yang, Z., Chen, Z., Zhang, C., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102082 · Cited by 92
The aged extracellular matrix and the profibrotic role of senescence-associated secretory phenotype
Mebratu, Y. A., Soni, S., Rosas, L., Rojas, M. M., Horowitz, J. C., & Nho, R. S. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00124.2023 · Cited by 95
Long noncoding RNA H19X is a key mediator of TGF-β–driven fibrosis
Pachera, E., Assassi, S., Salazar, G. A., Stellato, M., Renoux, F., Wunderlin, A. S., Błyszczuk, P., Lafyatis, R., Kurreeman, F. A. S., de Vries-Bouwstra, J. K., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135439 · Cited by 83
Tiskratok, W., Chuinsiri, N., Limraksasin, P., Kyawsoewin, M., & Jitprasertwong, P. (2025) · Polymers · doi:10.3390/polym17060822 · Cited by 99
Targeted apoptosis of myofibroblasts by elesclomol inhibits hypertrophic scar formation
Feng, Y., Wu, J., Sun, Z., Liu, S., Zou, M., Yuan, Z., Yu, S., Lv, G., & Yuan, F. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102715 · Cited by 81
Cardiovascular Disease: An Introduction
Thiriet, M. (2018) · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems · doi:10.1007/978-3-319-89315-0_1 · Cited by 91
Cellular Senescence in Lung Fibrosis
Hernández‐González, F., Faner, R., Rojas, M. M., Agustí, A. G. N., Serrano, M., & Sellarés, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137012 · Cited by 79
Cooley, J. C., Javkhlan, N., Wilson, J. A., Foster, D. G., Edelman, B., Ortiz, L. A., Schwartz, D. A., Riches, D. W. H., & Redente, E. F. (2023) · JCI Insight · doi:10.1172/jci.insight.163762 · Cited by 78
Fibroblast activation and heterogeneity in fibrotic disease
Zhang, X., Zhang, Y., & Liu, Y. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-025-00969-8 · Cited by 86
Louault, K., Bonneaud, T. L., Séveno, C., Gomez‐Bougie, P., Nguyen, F., Gautier, F., Bourgeois, N., Loussouarn, D., Kerdraon, O., Barillé‐Nion, S., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0635-z · Cited by 72
A primer to traction force microscopy
Zancla, A., Mozetic, P., Orsini, M., Forte, G., & Rainer, A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101867 · Cited by 70
Senolytic Agent Navitoclax Inhibits Angiotensin II-Induced Heart Failure in Mice
Jia, K., Dai, Y., Liu, A., Li, X., Wu, L., Lu, L., Bao, Y., & Jin, Q. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000878 · Cited by 71
Senescence and tissue fibrosis: opportunities for therapeutic targeting
O’Reilly, S., Tsou, P., & Varga, J. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.05.012 · Cited by 67
IL-13RA2 downregulation in fibroblasts promotes keloid fibrosis via JAK/STAT6 activation
Chao, H., Zheng, L., Hsu, P., He, J., Wu, R., Xu, S., Zeng, R., Zhou, Y., Ma, H., Liu, H., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.157091 · Cited by 66
Matrix stiffness controls cardiac fibroblast activation through regulating YAP via AT 1 R
Niu, L., Jia, Y., Wu, M., Liu, H., Feng, Y., Hu, Y., Zhang, X., Gao, D., Xu, F., & Huang, G. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29678 · Cited by 60
Dańczak‐Pazdrowska, A., Gornowicz‐Porowska, J., Polańska, A., Krajka‐Kuźniak, V., Stawny, M., Gostyńska, A., Rubiś, B., Noureddine, S. A., Ashiqueali, S., Schneider, A., et al. (2023) · Aging Cell · doi:10.1111/acel.13845 · Cited by 65
Yuh, D., Maekawa, T., Li, X., Kajikawa, T., Bdeir, K. H., Chavakis, T., & Hajishengallis, G. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013024 · Cited by 58
Senescence under appraisal: hopes and challenges revisited
Davan-Wetton, C. S. A., Pessolano, E., Perretti, M., & Montero‐Melendez, T. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03746-x · Cited by 61
Targeting Cpt1a-Bcl-2 interaction modulates apoptosis resistance and fibrotic remodeling
Gu, L., Surolia, R., Larson‐Casey, J. L., He, C., Davis, D., Kang, J., Antony, V. B., & Carter, A. B. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00840-w · Cited by 59
Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis
Zhou, S., Zhu, J., Zhou, P., & Gu, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.999600 · Cited by 58
Sitia, L., Bonizzi, A., Mazzucchelli, S., Negri, S., Sottani, C., Grignani, E., Rizzuto, M. A., Prosperi, D., Sorrentino, L., Morasso, C., et al. (2021) · Cells · doi:10.3390/cells10020328 · Cited by 56
Rehan, M., Kurundkar, D., Kurundkar, A., Logsdon, N. J., Smith, S. R., Chanda, D., Bernard, K. F., Sanders, Y. Y., Deshane, J. S., Dsouza, K. G., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00027-5 · Cited by 57
Lescoat, A., Varga, J., Matucci‐Cerinic, M., & Khanna, D. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1923693 · Cited by 53
Merkt, W., Zhou, Y., Han, H., & Lagares, D. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12952 · Cited by 62
Self-citationBasalova, N. A., Alexandrushkina, N. A., Grigorieva, O., Kulebyakina, M., & Efimenko, A. Y. (2023) · Biomolecules · doi:10.3390/biom13121718 · Cited by 56
Kühl, T., & Lagares, D. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.020 · Cited by 49
Self-citationSenolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells
Lafontaine, J., Cardin, G. B., Malaquin, N., Boisvert, J.-S., Rodier, F., & Wong, P. (2021) · Cancers · doi:10.3390/cancers13030386 · Cited by 54
Cellular census of human fibrosis defines functionally distinct stromal cell types and states
Layton, T. B., Williams, L. M., McCann, F. E., Zhang, M., Fritzsche, M., Colin‐York, H., Cabrita, M., Ng, M., Feldmann, M., Sansom, S. N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16264-y · Cited by 48
Tissue mechanics coevolves with fibrillar matrisomes in healthy and fibrotic tissues
Dooling, L. J., Saini, K., Anlaş, A. A., & Discher, D. E. (2022) · Matrix Biology · doi:10.1016/j.matbio.2022.06.006 · Cited by 46
The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo
Xu, N., Hua, Z., Ba, G., Zhang, S., Liu, Z., Thiele, C. J., & Li, Z. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1107-1 · Cited by 44
Tajaldini, M., Saeedi, M., Amiriani, T., Amiriani, A., Sedighi, S., Zadeh, F. M., Dehghan, M. H., Jahanshahi, M., Zanjan, M. G., Khalili, P., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175087 · Cited by 46
Elimination of p19ARF‐expressing cells protects against pulmonary emphysema in mice
Mikawa, R., Suzuki, Y., Baskoro, H., Kanayama, K., Sugimoto, K., Sato, T., & Sugimoto, M. (2018) · Aging Cell · doi:10.1111/acel.12827 · Cited by 44
Cuprous oxide nanoparticles reduces hypertrophic scarring by inducing fibroblast apoptosis
Xiao, Y., Xu, D., Song, H., Shu, F., Pei, W., Yang, X., Zhong, C., Wang, X., Müller, W. E. G., Zheng, Y., et al. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s196794 · Cited by 44
Current and Potential New Targets in Systemic Sclerosis Therapy: a New Hope
Hinchcliff, M., & O’Reilly, S. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00918-3 · Cited by 41
Lysyl oxidase enzymes mediate TGF-β1-induced fibrotic phenotypes in human skin-like tissues
Huang, M., Liu, Z., Baugh, L. M., DeFuria, J., Maione, A. G., Smith, A., Kashpur, O., Black, L. D., Georgakoudi, I., Whitfield, M. L., et al. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0159-8 · Cited by 41
Huang, M., Cai, G., Baugh, L. M., Liu, Z., Smith, A., Watson, M. C., Popovich, D., Zhang, T., Stawski, L., Trojanowska, M. E., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41163 · Cited by 40
Thrown for a loop: fibro-adipogenic progenitors in skeletal muscle fibrosis
Loomis, T., & Smith, L. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00245.2023 · Cited by 39
Uceda-Castro, R., Margarido, A. S., Cornet, L., Vegna, S., Hahn, K., Song, J., Putavet, D. A., van Geldorp, M., Çitirikkaya, C. H., de Keizer, P. L. J., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100821 · Cited by 40
Tajaldini, M., Poorkhani, A., Amiriani, T., Amiriani, A., Javid, H., Aref, P., Ahmadi, F., Sadani, S., & Khori, V. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175991 · Cited by 38
Chronic lung diseases: prospects for regeneration and repair
Barnes, P. J., Anderson, G. P., Fagerås, M., & Belvisi, M. G. (2021) · European Respiratory Review · doi:10.1183/16000617.0213-2020 · Cited by 35
Upcoming treatments for morphea
Wenzel, D., Haddadi, N., Afshari, K., Richmond, J. M., & Rashighi, M. (2021) · Immunity Inflammation and Disease · doi:10.1002/iid3.475 · Cited by 36
Novel approaches to target fibroblast mechanotransduction in fibroproliferative diseases
Ezzo, M., & Hinz, B. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108528 · Cited by 39
Fibrosis in burns: an overview of mechanisms and therapies
Faour, S., Farahat, M., Aijaz, A., & Jeschke, M. G. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00254.2023 · Cited by 40
Dakkak, B. E., Taneera, J., El‐Huneidi, W., Abu‐Gharbieh, E., Hamoudi, R., Semreen, M. H., Soares, N. C., Abu-rish, E. Y., Alkawareek, M. Y., Alkilany, A. M., et al. (2024) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.149 · Cited by 36
Progressive lung fibrosis: reprogramming a genetically vulnerable bronchoalveolar epithelium
Bridges, J. P., Vladar, E. K., Kurche, J. S., Krivoi, A., Stancil, I. T., Dobrinskikh, E., Hu, Y., Sasse, S. K., Lee, J. S., Blumhagen, R. Z., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci183836 · Cited by 41
p53 and Myofibroblast Apoptosis in Organ Fibrosis
McElhinney, K., Irnaten, M., & O'Brien, C. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076737 · Cited by 37
Aging, senescence, and cutaneous wound healing—a complex relationship
O’Reilly, S., Markiewicz, E., & Idowu, O. C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1429716 · Cited by 41
Recent developments in the pathobiology of lung myofibroblasts
Jiang, D., Dey, T., & Liu, G. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1829972 · Cited by 34
Nocquet, L., Juin, P. P., & Souazé, F. (2020) · Cancers · doi:10.3390/cancers12103017 · Cited by 34
siRNA-mediated protein knockdown in precision-cut lung slices
Ruigrok, M. J. R., Xian, J. L., Frijlink, H. W., Melgert, B. N., Hinrichs, W. L. J., & Olinga, P. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.11.005 · Cited by 33
Modeling Progressive Fibrosis with Pluripotent Stem Cells Identifies an Anti-fibrotic Small Molecule
Vijayaraj, P., Minasyan, A., Durra, A., Karumbayaram, S., Mehrabi, M., Aros, C. J., Ahadome, S. D., Shia, D. W., Chung, K., Sandlin, J. M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.019 · Cited by 34
Hwang, W. L., Jagadeesh, K. A., Guo, J. A., Hoffman, H. I., Yadollahpour, P., Mohan, R. R., Drokhlyansky, E., Wittenberghe, N. V., Ashenberg, O., Farhi, S. L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.25.267336 · Cited by 35
Zhu, L., Liu, L., Wang, A., Liu, J., Huang, X., & Zan, T. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.05.001 · Cited by 36
Shen, M., Fu, J., Zhang, Y., Chang, Y., Li, X., Cheng, H., Qiu, Y., Shao, M., Han, Y., Zhou, Y., et al. (2024) · Aging Cell · doi:10.1111/acel.14229 · Cited by 33
Stress responses in stromal cells and tumor homeostasis
Vitale, I., Manic, G., Galassi, C., & Galluzzi, L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.004 · Cited by 33
Rehman, M., Vodret, S., Braga, L., Guarnaccia, C., Celsi, F., Rossetti, G., Martinelli, V. C., Battini, T., Long, C. S., Vukušić, K., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.123987 · Cited by 30
You Say You Want a Resolution (of Fibrosis)
Atabai, K., Yang, C. D., & Podolsky, M. J. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0182tr · Cited by 30
Zhang, J., Ji, K., Ning, Y., Sun, L., Fan, M., Shu, C., Zhang, Z., Tu, T., Cao, J., Gao, F., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c12831 · Cited by 30
Al-Hilal, T. A., Chrysovergi, M.-A., Grasberger, P. E., Liu, F., Auernheimer, V., Zhou, Y., Xiao, Z., Duque, M. A. L., Santos, A., Islam, T., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01697-8 · Cited by 36
Self-citationA model for positive feedback control of the transformation of fibroblasts to myofibroblasts
Elson, E. L., Qian, H., Fee, J. A., & Wakatsuki, T. (2018) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2018.08.004 · Cited by 30
Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
Castro, N., Gillespie, S. R., & Bernstein, A. M. (2019) · Journal of Visualized Experiments · doi:10.3791/58562 · Cited by 36
Insights into myofibroblasts and their activation in scleroderma: opportunities for therapy?
Gyftaki-Venieri, D. A., Abraham, D., & Ponticos, M. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000543 · Cited by 30
Leong, E. K., Bezuhly, M., & Marshall, J. S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.727451 · Cited by 29
Wertheim, B. M., Wang, R., Guillermier, C., Hütter, C. V. R., Oldham, W. M., Menche, J., Steinhauser, M. L., & Maron, B. A. (2023) · JCI Insight · doi:10.1172/jci.insight.163932 · Cited by 29
Urokinase Plasminogen Activator Overexpression Reverses Established Lung Fibrosis
Horowitz, J. C., Tschumperlin, D. J., Kim, K. K., Osterholzer, J. J., Subbotina, N., Ajayi, I. O., Teitz‐Tennenbaum, S., Virk, A. Q., Dotson, M. R., Liu, F., et al. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1697953 · Cited by 28
Self-citationThiery, J. (2022) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2022.00103 · Cited by 29
Regulation of fibroblast Fas expression by soluble and mechanical pro-fibrotic stimuli
Dodi, A. E., Ajayi, I. O., Chang, C. J., BEARD, M., Ashley, S. L., Huang, S. K., Thannickal, V. J., Tschumperlin, D. J., Sisson, T. H., & Horowitz, J. C. (2018) · Respiratory Research · doi:10.1186/s12931-018-0801-4 · Cited by 27
Self-citationABT-263 Reduces Hypertrophic Scars by Targeting Apoptosis of Myofibroblasts
Yang, X., Xiao, Y., Zhong, C., Shu, F., Xiao, S., Zheng, Y., & Xia, Z. (2020) · Frontiers in Pharmacology · doi:10.2139/ssrn.3698857 · Cited by 28
Transcriptomic and Proteomic Changes Driving Pulmonary Fibrosis Resolution in Young and Old Mice
Weckerle, J., Mayr, C. H., Fundel‐Clemens, K., Lämmle, B., Boryń, Ł. M., Thomas, M. J., Bretschneider, T., Luippold, A. H., Huber, H. J., Viollet, C., et al. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0012oc · Cited by 25
Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing
Shvedova, M., Thanapaul, R. J. R. S., Ha, J., Dhillon, J., Shin, G. H., Crouch, J., Gower, A. C., Gritli, S., & Roh, D. S. (2025) · Aging · doi:10.18632/aging.206165 · Cited by 26
Network-based modeling of drug effects on disease module in systemic sclerosis
Kim, K., Moon, S., Park, K., & Tagkopoulos, I. (2020) · Scientific Reports · doi:10.1038/s41598-020-70280-y · Cited by 24
Metadata
- Authors
- Lagares, D., Santos, A., Grasberger, P. E., Liu, F., Probst, C. K., Rahimi, R. A., Sakai, N., Kuehl, T., Ryan, J., Bhola, P., Montero, J., Kapoor, M., Baron, M., Varelas, X., Tschumperlin, D. J., Letai, A., & Tager, A. M.
- Affiliations
- Harvard University (US)
- Fibrosis Research Center and Center for Immunology and Inflammatory Diseases, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
- University Health Network (CA)
- Jewish General Hospital (CA)
- Boston University (US)
- Mayo Clinic (US)
- Corresponding author
- Lagares, David
- Santos, Alba
- Grasberger, Paula E.
- Tager, Andrew M.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2017-12-13
- Volume
- 9
- Issue
- 420
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC8520471
- OpenAlex
- W2774171294
- Cited by
- 246
- References
- 63
- Citations by year
- 2026: 31 · 2025: 25 · 2024: 30 · 2023: 36 · 2022: 21 · 2021: 34 · 2020: 28 · 2019: 23 · 2018: 17 · 2017: 1
- FWCI
- 14.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (2r01hl092961-13)
- National Heart, Lung, and Blood Institute (R01-HL-092961, R01HL108975, K08HL140173)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- navitoclax, BH3 mimetics, myofibroblast apoptosis, systemic sclerosis, skin fibrosis, fibrosis reversal, mitochondrial priming, BH3 profiling, anti-apoptotic proteins, drug response prediction
- MeSH terms
- Aniline Compounds, Animals, Biomechanical Phenomena, Cell Survival, Disease Models, Animal, Extracellular Matrix, Fibrosis, Humans, Male, Mice, Inbred C57BL, Mitochondria, Scleroderma, Systemic, Sulfonamides, Signal Transduction, Apoptosis, Dermis, Mechanotransduction, Cellular, bcl-X Protein, Mitochondrial Membranes, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
